Faculty
Veronika Bachanova, MD, PhD
Professor of Medicine
Lead of Lymphoma Interdisciplinary Team at University of Minnesota Cell Therapies Clinical Director
Section Head, Malignant Hematology
Division of Hematology, Oncology, and Transplantation
University of Minnesota
 
Peminda Cabandugama, MD
Diplomate, American Board of Obesity Medicine
Director, Digital Obesity Programs
Cleveland Clinic
 
Kirk Campbell, MD
Professor of Medicine
Professor of Pharmacological Sciences
Icahn School of Medicine at Mount Sinai
 
Arpana Church, PhD
Associate Professor and Co-Director
Goodman-Luskin Microbiome Center
Director, Neuroimaging Core
Director, Obesity, Metabolic Disorders and Eating Behaviors
G. Oppenheimer Center for Neurobiology of Stress and Resilience
UCLA Vatche and Tamar Manoukian Division of Digestive Diseases
David Geffen School of Medicine
UCLA Health
 
Gerard J. Criner, MD, FACP, FACCP
Chair and Professor,
Thoracic Medicine and Surgery
Lewis Katz School of Medicine at Temple University;
Director, Temple Lung Center
Temple Health
 
Robert McCarron, DO
Director of Education
Susan Samueli Integrative Health Institute;
Associate Dean, SOM Continuing Medical Education
Director, Train New Trainers (TNT) Primary Care Psychiatry (PCP) and
Training and Education in Addiction Medicine (TEAM) Fellowships
UC Irvine
 
Navneet Majhail, MD, MS, FASTCT
Physician-in-Chief of Blood Cancers
Director, Sarah Cannon Transplant and Cellular Therapy Program at TriStar Centennial
Sarah Cannon Cancer Institute
 
David F. Mercer, MD, PhD, FRCS (C), FACS
Professor, Department of Surgery, Division of Transplantation
Director of Intestinal Rehabilitation Program
University of Nebraska Medical Center
 
David E. Midthun, MD
Professor of Medicine
Pulmonologist
Mayo Clinic
 
Kendall Moseley, MD
Clinical Director, Division of Endocrinology, Diabetes & Metabolism
Medical Director, Johns Hopkins Metabolic Bone & Osteoporosis Center
Co-Director, Johns Hopkins Multidisciplinary Parathyroid Clinic
Associate Professor of Clinical Medicine
Johns Hopkins Medicine
 
Marie Neumann, MA
Co-founder, The Gutsy Perspective
Parent of a child with SBS-IF
Researcher
University of Nebraska Medical Center
 
Jimi Olaghere
Tech Entrepreneur
Sickle Cell Disease Patient Advocate
Gene Therapy Recipient
 
Trishan Panch, MD, MPH
Co-Founder, Wellframe
President
Harvard T.H. Chan School of Public Health Alumni Association
Instructor
Harvard T.H. Chan School of Public Health
 
Joseph G. Rogers, MD
President and Chief Executive Officer
O'Quinn/Willerson Endowed Chair
The Texas Heart Institute
 
Vinayak S. Rohan, MD, FACS
Associate Professor of Surgery
Surgical Director of Kidney Transplantation
Division of Abdominal Transplant Surgery
Northwestern University, Feinberg School of Medicine
Northwestern Medicine
 
Ahmet Uluer, DO, MPH
Director, BRIDGES Adult Transition Program
Director, Adult Cystic Fibrosis Program
Assistant Professor of Pediatrics, Harvard Medical School
Boston Children's Hospital
 
Brandon P. Verdoorn, MD, CMD
Program Director, Mayo Clinic Geriatric Medicine fellowship
Geriatrician and Internist
Mayo Clinic
 
Planners
Elizabeth Albert, MD
Clinical Activity Manager
Optum Health Education
Eden Prairie, MN

Sara Fleszar, PharmD, BCOP
Senior Clinical Pharmacist
Optum Health Solutions

Rebecca Gleason, RN, CCM
Activity Manager
Optum Health Education
Eden Prairie, MN

Lisa Latts, MD, MSPH, MBA, FACP
Senior Medical Director, Value-Based Care
Optum
Eden Prairie, MN

Katie L. Lo Coco RN, BSN, CCTC, CCM
Clinical Operations Manager for Transplant Solutions M&R
Optum Health

Disclosures of relevant financial relationships
In accordance with the Accreditation Council for Continuing Medical Education's (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, OptumHealth Education (OHE) requires all those in control of educational content to disclose their financial relationships with ineligible companies within the prior 24 months. Ineligible companies are defined by the ACCME as companies whose primary business is producing, marketing, selling, re-selling, or distributing health care products used by or on patients. Individuals must disclose all financial relationships, regardless of the amount, with ineligible companies and regardless of their view of the relevance of the relationship to the education. OHE ensures that the content is independent of commercial bias.

The list below includes individuals that have relevant financial relationships. 
Financial Relationship Key A-Advisory Board CT-Clinical Trial C-Consultant E-Employee G- Grant/Research Support or Funding I-Stocks and Other Ownership Interests S-Speakers’ Bureau O-Other Financial or Material Support

• Veronika Bachanova, MD, PhD: Citius, Gamida Cell, Incyte (G); Astra Zeneca (A)
• Peminda Cabandugama, MD: Eli Lilly (S)
• Kirk Campbell, MD: Novartis, Calliditas, Travere, Sanofi, AstraZeneca, Maze (C) 
• Robert McCarron, DO: Alkermes (S)
• David Mercer, MD, PhD, FRCS (C), FACS: Zealand Pharma (A, G); Vective Bio, Takeda (G)
• Marie Neumann, MA: Takeda Pharmaceuticals, Ironwood Pharmaceuticals, Zealand Pharma (C, G, S)
• Trishan Panch, MD, MPH: Lumin, Healthedge (I)
• Vinayak S. Rohan, MD, FACS: Merck (S); Mesh Suture Inc. (C) 
• Brandon P. Verdoorn, MD, CMD: Bristol Myers Squibb, Walgreens Boots Alliance (I)

All relevant financial relationships have been mitigated. 

The remaining activity faculty or planners have no financial relationships to disclose.